Science
Stephen V Liu: Predicting Benefit From Perioperative Nivolumab in Patients With Resectable NSCLC
Stephen Liu/X

Stephen V Liu: Predicting Benefit From Perioperative Nivolumab in Patients With Resectable NSCLC

Stephen V Liu, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared on X:

“Nature publication today from Dr. Tina Cascone et al with tremendous detail on biomarkers from CheckMate 77T predicting benefit from perioperative nivolumab in patients with resectable NSCLC. Amazing amount of detailed data in this Nature paper.”

Title: Biomarkers of nivolumab benefit in resectable non-small cell lung cancer

Authors: Tina Cascone, Mark M. Awad, Jonathan D. Spicer, Jie He, Shun Lu, Fumihiro Tanaka, Robin Cornelissen, Lubos B. Petruzelka, Yang Gao, Jean-Louis Pujol, Hiroyuki Ito, Ludmila de Oliveira Muniz Koch, Tudor-Eliade Ciuleanu, Lin Wu, Sabine Bohnet, Yasutaka Watanabe, Janis M. Taube, Julie Stein Deutsch, Cinthya Coronado Erdmann, Stephanie Meadows-Shropshire, Jaclyn Neely, Virginia Ip, Yu-Han Hung, Padma Sathyanarayana, Sumeena Bhatia, Katherine Chu, Steven I. Blum, Stefano Lucherini, Nathanial Eddy, Akshay Yadav, Mariano Provencio

Read the Article

Other articles featuring Stephen V Liu on OncoDaily.

Akshay Yadav cancer CheckMate-77T Cinthya Coronado Erdmann Fumihiro Tanaka Hiroyuki Ito Jaclyn Neely Janis M. Taube Jean-Louis Pujol Jie He Jonathan D. Spicer Julie Stein Deutsch Katherine Chu Lin Wu Lubos B. Petruzelka Ludmila de Oliveira Muniz Koch Lung cancer Mariano Provencio Mark M. Awad Nathanial Eddy NSCLC OncoDaily Oncology Padma Sathyanarayana Robin Cornelissen Sabine Bohnet Shun Lu Stefano Lucherini Stephanie Meadows-Shropshire Stephen V Liu Steven I. Blum Sumeena Bhatia Tina Cascone Tudor-Eliade Ciuleanu Virginia Ip Yang Gao Yasutaka Watanabe Yu-Han Hung